Seizure and epilepsy risk up in six months after COVID-19: study
The incidence of new seizures or epilepsy is increased in patients in the six months following COVID-19 compared with matched patients with influenza, according to…
The incidence of new seizures or epilepsy is increased in patients in the six months following COVID-19 compared with matched patients with influenza, according to…
Nordic registry-based study implicates valproate and topiramate in childhood risk of ASD and intellectual disability.
The findings suggest many guidelines on prophylactic antiepileptic medication and driving restrictions may need overhaul, the authors say.
Neurologists have conducted an audit of Melbourne patients across two decades.
Large study using UK data examines the risk of enzyme-inducing medications.
Australian neurologists identify the featu…
The effect is likely due to rhythm, tone and other acoustic properties, researchers say.
Older agents, however, confer no more risk than newer non-enzyme-inducing drugs, researchers find.
The largest observational study to date provides reassurance, US researchers say.
The child was being treated for epilepsy by his mother using cannabis oil bought online.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.